Paul Conway

472 total citations
25 papers, 374 citations indexed

About

Paul Conway is a scholar working on Cellular and Molecular Neuroscience, Organic Chemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paul Conway has authored 25 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 7 papers in Organic Chemistry and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paul Conway's work include Neuroscience and Neuropharmacology Research (5 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Paul Conway is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Paul Conway collaborates with scholars based in United States, Australia and Canada. Paul Conway's co-authors include David J. Brunswick, Norman J. Uretsky, Shanaz M. Tejani‐Butt, Carole A. Wilmot, Joseph T. Strupczewski, Roy Corbett, Mark R. Szewczak, Harold B. Hartman, Alan Frazer and Leonardo Tondo and has published in prestigious journals such as Journal of Medicinal Chemistry, PLoS Biology and Journal of Neurochemistry.

In The Last Decade

Paul Conway

24 papers receiving 353 citations

Peers

Paul Conway
Kenneth L. Hauser United States
Jonas A. Gylys United States
F. E. SOROKO United States
A.T. Kilpatrick United Kingdom
M. Sandier United Kingdom
Jan R. Flynn United States
Kenneth L. Hauser United States
Paul Conway
Citations per year, relative to Paul Conway Paul Conway (= 1×) peers Kenneth L. Hauser

Countries citing papers authored by Paul Conway

Since Specialization
Citations

This map shows the geographic impact of Paul Conway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Conway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Conway more than expected).

Fields of papers citing papers by Paul Conway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Conway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Conway. The network helps show where Paul Conway may publish in the future.

Co-authorship network of co-authors of Paul Conway

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Conway. A scholar is included among the top collaborators of Paul Conway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Conway. Paul Conway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conway, Paul, Zijun Wang, Clara Ortega‐de San Luis, et al.. (2025). Extinction and subsequent updating of innate fear responses to a visual looming stimulus rely on hippocampus-dependent mechanisms. PLoS Biology. 23(9). e3003391–e3003391.
3.
See, Andrew, Paul Conway, Mark Frydenberg, et al.. (2024). Five‐year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trial. International Journal of Cancer. 155(7). 1248–1256. 4 indexed citations
4.
Hamilton, Daniel G., et al.. (2023). Radiation necrosis and therapeutic outcomes in patients treated with linear accelerator‐based hypofractionated stereotactic radiosurgery for intact intracranial metastases. Journal of Medical Imaging and Radiation Oncology. 67(3). 308–319. 1 indexed citations
5.
Conway, Paul, et al.. (2021). Oesophageal cancer treatment patterns, timeliness of care and outcomes in the Loddon Mallee region of Victoria: A retrospective cohort study. Journal of Medical Imaging and Radiation Oncology. 65(2). 242–250. 1 indexed citations
6.
Conway, Paul, Carel Pretorius, Jacobus Ungerer, et al.. (2015). Cortisol responses at baseline and after corticotropin in acute aneurysmal subarachnoid haemorrhage: a prospective study. Critical Care and Resuscitation. 17(1). 37–42. 1 indexed citations
7.
Szczepanik, A. M., et al.. (1996). Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.. Journal of Pharmacology and Experimental Therapeutics. 278(2). 913–920. 11 indexed citations
8.
Strupczewski, Joseph T., Edward J. Glamkowski, Paul Conway, et al.. (1995). 3-[[(Aryloxy)alkyl]piperidinyl]-1,2-Benzisoxazoles as D2/5-HT2 Antagonists with Potential Atypical Antipsychotic Activity: Antipsychotic Profile of Iloperidone (HP 873). Journal of Medicinal Chemistry. 38(7). 1119–1131. 66 indexed citations
9.
Szewczak, Mark R., Roy Corbett, Douglas K. Rush, et al.. (1995). The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.. Journal of Pharmacology and Experimental Therapeutics. 274(3). 1404–1413. 43 indexed citations
10.
Burgher, Kendra L., et al.. (1994). Benzisoxazole- and Benzisothiazole-3-carboxamides as Potential Atypical Antipsychotic Agents. Journal of Medicinal Chemistry. 37(15). 2308–2314. 28 indexed citations
11.
12.
Conway, Paul, et al.. (1991). Effect of ritanserin on the interaction of amfonelic acid and neuroleptic-induced striatal dopamine metabolism. Neuropharmacology. 30(10). 1137–1140. 9 indexed citations
13.
Hubbard, John W., et al.. (1990). Cardiac adenylate cyclase activity, positive chronotropic and inotropic effects of forskolin analogs with either low, medium or high binding site affinity.. Journal of Pharmacology and Experimental Therapeutics. 256(2). 621–627. 6 indexed citations
14.
Hartman, Harold B., et al.. (1988). HP 663: A novel compound for the treatment of glaucoma. Drug Development Research. 12(3-4). 197–209. 3 indexed citations
15.
Tondo, Leonardo, Paul Conway, & David J. Brunswick. (1985). Labeling in vivo of beta adrenergic receptors in the central nervous system of the rat after administration of [125I] iodopindolol.. Journal of Pharmacology and Experimental Therapeutics. 235(1). 1–9. 28 indexed citations
17.
Conway, Paul & Norman J. Uretsky. (1983). Enhanced stereotyped response to amphetamine after pretreatment with small doses of molindone☆. Neuropharmacology. 22(5). 579–586. 5 indexed citations
18.
Conway, Paul & Norman J. Uretsky. (1982). Role of striatal dopaminergic receptors in amphetamine-induced behavioral facilitation.. Journal of Pharmacology and Experimental Therapeutics. 221(3). 650–655. 39 indexed citations
19.
Conway, Paul, et al.. (1980). A new and unusual isomerism in [Fe(CO)2 {P(OR)3}2 (SO2)] complexes (R = aryl). Journal of Organometallic Chemistry. 186(3). C61–C63. 5 indexed citations
20.
Conway, Paul, et al.. (1979). Preparation, ligand-exchange reactions, and alkylation reactions of some carbon disulphide derivatives of iron. Journal of the Chemical Society Dalton Transactions. 1920–1920. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026